PALA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 3.835
EU - Europa 2.677
AS - Asia 1.608
SA - Sud America 189
Continente sconosciuto - Info sul continente non disponibili 44
AF - Africa 38
OC - Oceania 25
Totale 8.416
Nazione #
US - Stati Uniti d'America 3.787
RU - Federazione Russa 865
PL - Polonia 567
IT - Italia 543
SG - Singapore 467
CN - Cina 391
HK - Hong Kong 250
IE - Irlanda 202
SE - Svezia 168
VN - Vietnam 162
BR - Brasile 153
KR - Corea 116
FR - Francia 81
DE - Germania 68
FI - Finlandia 62
JO - Giordania 49
IN - India 43
CA - Canada 33
GB - Regno Unito 29
BD - Bangladesh 27
NL - Olanda 26
AU - Australia 24
CH - Svizzera 18
ID - Indonesia 18
JP - Giappone 17
TR - Turchia 17
UA - Ucraina 16
ES - Italia 13
AR - Argentina 12
IQ - Iraq 12
ZA - Sudafrica 12
EC - Ecuador 9
BE - Belgio 8
MX - Messico 7
AE - Emirati Arabi Uniti 6
CI - Costa d'Avorio 6
CO - Colombia 6
CL - Cile 4
MY - Malesia 4
NG - Nigeria 4
AZ - Azerbaigian 3
DZ - Algeria 3
IR - Iran 3
LV - Lettonia 3
MA - Marocco 3
NP - Nepal 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
AM - Armenia 2
AT - Austria 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
LT - Lituania 2
MM - Myanmar 2
PH - Filippine 2
PT - Portogallo 2
SV - El Salvador 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
BG - Bulgaria 1
CR - Costa Rica 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
SX - ???statistics.table.value.countryCode.SX??? 1
TH - Thailandia 1
Totale 8.374
Città #
Santa Clara 814
Warsaw 565
Ashburn 480
Singapore 341
Fairfield 304
Chandler 217
Hong Kong 205
Dublin 202
Seattle 148
Woodbridge 136
Cambridge 131
San Jose 123
Seoul 116
Wilmington 111
Milan 109
Houston 101
Beijing 100
Buffalo 71
Ann Arbor 70
Los Angeles 59
Dallas 58
Ho Chi Minh City 50
Rome 50
Princeton 49
Altamura 48
Lawrence 47
Hefei 44
The Dalles 44
Lauterbourg 40
Florence 36
Hanoi 36
Boston 30
Moscow 29
Jacksonville 28
Paris 28
Kent 26
New York 26
San Diego 26
Shanghai 25
Munich 24
Melbourne 23
Mumbai 23
Helsinki 22
Council Bluffs 21
São Paulo 20
Medford 19
Naples 19
Bern 16
Boardman 16
Tokyo 16
Dong Ket 14
Wageningen 13
Orem 12
Philadelphia 12
London 11
Turin 11
Bologna 10
Frankfurt am Main 10
Jakarta 10
Clifton 9
Montreal 9
Brussels 8
Falls Church 8
Phoenix 8
San Francisco 8
Stockholm 8
Catania 7
Haiphong 7
Izmir 7
Norwalk 7
Venice 7
Abidjan 6
Andover 6
Baghdad 6
Figino 6
Guangzhou 6
Istanbul 6
Johannesburg 6
Redondo Beach 6
Toronto 6
Amman 5
Chicago 5
Da Nang 5
Falkenstein 5
Hillsboro 5
Miano 5
Padua 5
Palermo 5
Perugia 5
Quito 5
Tianjin 5
Turku 5
Bari 4
Bolzano 4
Brasília 4
Charlotte 4
Chennai 4
Dhaka 4
Dubai 4
Mexico City 4
Totale 5.684
Nome #
Fit and motivated: outcome predictors in patients starting a program for lifestyle change. 323
Inflammatory molecules affect the interaction between human dendritic cells and vascular smooth muscle cells 277
The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence. 272
The therapy of insulin resistance in other diseases besides type 2 diabetes. 242
False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change. 242
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 228
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study 223
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials 220
Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients 217
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study 200
Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. 196
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 194
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials 193
Dendritic cell phenotype and function are modulated by inflammation and insulin-resistance. 184
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 180
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells 179
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 177
Clinical approach to diabetic cardiomyopathy: A review of human studies 175
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 174
Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function 173
Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better? 168
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 166
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 166
Role of insulin in the type 2 diabetes therapy: past, present and future. 164
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 161
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study) 160
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) project 159
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 157
Periodontitis predicts HbA1c levels and glucose variability in type 1 diabetic patients: the PARODIA Florence Project study 155
Orthorexia nervosa and type 1 diabetes: results of a cross-sectional study 154
Assessment of left ventricular global longitudinal strain in patients with type 2 diabetes: Relationship with microvascular damage and glycemic control 154
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 152
Meccanismi infiammatori regolano le interazioni tra cellule muscolari coronariche lisce e cellule dendritiche umane 151
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 144
Studio del fenotipo delle cellule dendritiche di pazienti obesi ed insulino resistenti e della loro interazione con cellule muscolari lisce coronariche umane. 144
Online group lifestyle modification programs for obesity during the COVID-19 pandemic: The EDucation ONline (EDON) retrospective study 143
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 143
Motivational enhancement therapy in obese patients: A promising application 137
Time to insulin in type-2 diabetes: high hurdles or Santiago way? 134
Long-term interactive group education for type 1 diabetic patients 132
Motivational readiness for treatment in weight control programs: the treatment motivation and readiness (tre-more) test 131
Characterization of dendritic cells in obese and diabetic patients 130
Correction to: Orthorexia nervosa and type 1 diabetes: results of a cross‑sectional study (Acta Diabetologica, (2023), 60, 5, (681-686), 10.1007/s00592-023-02044-9) 126
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 125
Obesity therapy: How and why? 117
Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trials 115
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project 110
MANAGEMENT OF HYPERGLICEMIA IN TYPE 2 DIABETES: A CONSENSUS ALGORITHM FOR THE INITIATION AND ADJUSTMENT OF THERAPY: A CONSENSUS STATEMENT FROM THE AMERICAN DIABETES ASSOCIATION AND THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES 103
The "slower" the better 94
Validation of a New Test for Assessing the Quality of Life Perceived in Patients with Type 1 Diabetes 27
Assessment of psychological predictors of weight loss: How and what for? 25
Totale 8.416
Categoria #
all - tutte 23.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022278 0 7 23 5 11 19 6 16 17 26 58 90
2022/2023900 75 178 38 79 47 155 112 42 122 4 20 28
2023/2024325 17 34 50 18 14 53 19 64 7 17 26 6
2024/20252.379 85 240 148 380 654 370 45 144 91 75 81 66
2025/20262.580 298 309 227 149 279 103 303 133 167 186 63 363
2026/202792 81 11 0 0 0 0 0 0 0 0 0 0
Totale 8.416